Lonza | LONN - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Akzo Nobel EUR 4.85B 28M 2026-06
Alcon AG USD 21.6B 538M 2026-06
Almirall EUR 1.53B 43.26M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
BASF EUR 36.32B 846M 2026-06
Bayer EUR 29.71B 863M 2026-06
Beiersdorf EUR 8.6B 133M 2025-12
Covestro EUR 7B 908M 2025-12
Demant DKK 11.24B 1.4B 2026-06
Fresenius EUR 19.7B 766M 2026-06
Fresenius Medical Care EUR 13.53B 673.44M 2026-06
Geberit CHF 1.54B 237.4M 2025-03
Genmab DKK 5.96B 275M 2026-06
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
GN Store Nord DKK 10.27B 146M 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Johnson Matthey GBP 2.02B 85M 2026-06
Merck EUR 30.17B 430M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Philips EUR 11.48B 84M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Sika AG CHF 6.66B 481.4M 2025-12
Smith & Nephew USD 5.18B 356M 2026-06
Solvay EUR 1.11B 70M 2026-06
UCB EUR 10.87B 1.18B 2025-12